News & Videos - CYTODYN INC. CYDY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CytoDyn Inc. - CYDY PR Newswire NEW YORK, Aug. 9, 2022 NEW YORK , Aug. 9, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of CytoDyn Inc. ("CytoDyn" or the "Company") (OTCMKTS: CYDY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether CytoDyn and certain of its officers and/or directors...

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CytoDyn Inc. (OTC: CYDY). Beginning in early 2020, the Company began pivoting its existing drug candidate, leronlimab, which was originally developed for the treatment of HIV, for use as a treatment for severe cases of COVID-19. On March 5, 2021, the Company issued a press release purporting to tout the positive...

SHAREHOLDER ALERT: CytoDyn Inc. (CYDY) Officers and Directors Under Investigation for Possible False Statements and Insider Trading PR Newswire SAN FRANCISCO, June 10, 2021 SAN FRANCISCO , June 10, 2021 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of CytoDyn Inc. (OTC: CYDY) relating to possible false statements to investors and insider trading by two officers and a director. In or around March 2020 , in the early stages of...

The Law Offices of Frank R. Cruz reminds investors of the upcoming May 17, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased CytoDyn, Inc. (“CytoDyn, Inc.” or the “Company”) (OTC: CYDY ) common stock between March 27, 2020 and March 9, 2021 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On August 26, 2020, The Wall Street Journal reported that, despite earlier...

The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Western District of Washington against CytoDyn Inc. (OTCMKTS: CYDY) (“CytoDyn”) on behalf of those who purchased or acquired CytoDyn common stock between March 27, 2020 and March 9, 2021 , inclusive (the “Class Period”). Deadline Reminder: Investors who purchased or acquired CytoDyn common stock during the Class Period may,...

Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc. (CYDY) PR Newswire RADNOR, Pa., May 3, 2021 RADNOR, Pa. , May 3, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that securities fraud class action lawsuit has been filed against CytoDyn Inc. (OTCMKTS: CYDY) ("CytoDyn") on behalf of those who purchased or acquired CytoDyn common stock between...

Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc. (CYDY) PR Newswire RADNOR, Pa., April 21, 2021 RADNOR, Pa. , April 21, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that securities fraud class action lawsuit has been filed against CytoDyn Inc. (OTCMKTS: CYDY) ("CytoDyn") on behalf of those who purchased or acquired CytoDyn common stock between March 27, 2020 and...

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CytoDyn, Inc. (CYDY) PR Newswire LOS ANGELES, April 19, 2021 LOS ANGELES , April 19, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming May 17, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired CytoDyn, Inc. ("CytoDyn" or the "Company") (OTC: CYDY) common stock between March...

Shareholder rights law firm Robbins LLP announces that a purchaser of CytoDyn Inc. (OTC: CYDY) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between March 27, 2020 and March 9, 2021. If you suffered a loss due to CytoDyn Inc.'s misconduct, click here . CytoDyn Inc. (CYDY) Misled Shareholders About the Viability of its Drug for the Treatment of COVID-19 CytoDyn is a biotech company that - prior to...

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CytoDyn, Inc. (CYDY) PR Newswire BENSALEM, Pa., April 7, 2021 BENSALEM, Pa. , April 7, 2021 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming May 17, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased CytoDyn, Inc. ("CytoDyn, Inc." or the "Company") (OTC: CYDY) common stock between March 27,...

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, announces the filing of a class action lawsuit against CytoDyn, Inc. (“CytoDyn”) (OTCQB: CYDY) and certain of its officers, alleging violations of federal securities laws. If you purchased CytoDyn shares between March 27, 2020 and March 9, 2021, inclusive, and have suffered a loss, you are encouraged to contact Joe Pettigrew for additional information at (844) 818-6982 or...

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CytoDyn, Inc. (CYDY) Investors PR Newswire LOS ANGELES, April 2, 2021 LOS ANGELES , April 2, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired CytoDyn, Inc. ("CytoDyn" or the "Company") (OTC: CYDY) common stock between March 27, 2020 and March 9, 2021 , inclusive (the "Class...

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 17, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired CytoDyn, Inc. (“CytoDyn” or the “Company”) (OTC: CYDY ) common stock between March 27, 2020 and March 9, 2021 , inclusive (the “Class Period”). If you suffered a loss on your CytoDyn investments or would like to inquire about potentially pursuing claims to recover your loss...

Law Offices of Howard G. Smith reminds investors of the upcoming May 17, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased CytoDyn, Inc. (“CytoDyn, Inc.” or the “Company”) (OTC: CYDY ) common stock between March 27, 2020 and March 9, 2021 , inclusive (the “Class Period”). Investors suffering losses on their CytoDyn, Inc. investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this...

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired CytoDyn, Inc. (“CytoDyn” or the “Company”) (OTC: CYDY ) common stock between March 27, 2020 and March 9, 2021 , inclusive (the “Class Period”). CytoDyn investors have until May 17, 2021 to file a lead plaintiff motion. If you are a shareholder who suffered a loss, click here to participate. On August 26, 2020, The Wall Street...

Shareholder rights law firm Robbins LLP is investigating CytoDyn Inc. (OTC: CYDY) on behalf of shareholders to determine whether certain CytoDyn officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. If you suffered a loss due to CytoDyn Inc.'s misconduct, click here . CytoDyn Inc. (CYDY) Misled Shareholders About the Viability of its Drug for the Treatment of COVID-19 CytoDyn is a biotech company that - prior to the COVID-19...

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased CytoDyn, Inc. (“CytoDyn” or the “Company”) (OTC: CYDY ) common stock between March 27, 2020 and March 9, 2021 , inclusive (the “Class Period”). CytoDyn investors have until May 17, 2021 to file a lead plaintiff motion. Investors suffering losses on their CytoDyn investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights...

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is investigating whether CytoDyn, Inc. (“CytoDyn” or the “Company”) (OTCQB: CYDY) or certain of its officers and directors violated federal securities laws. If you purchased or otherwise own CytoDyn stock, and have suffered a loss, you are encouraged to contact Scott+Scott attorney Joe Pettigrew at (844) 818-6982 or [email protected] for more information....

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of CytoDyn Inc. (“CytoDyn” or the “Company”) (OTC: CYDY ) investors concerning the Company and its officers’ possible violations of the federal securities laws. If you suffered a loss on your CytoDyn investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can...

...